N. Mounier

发表

A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior.

P. Ravaud, É. Lepage, P. Durieux, 2000, JAMA.

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

J. Raemaekers, M. Federico, N. Mounier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.

J. Rossi, G. Salles, R. Bouabdallah, 2008, Blood.

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.

T. Molina, F. Jardin, G. Salles, 2018, The Lancet. Haematology.

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

W. Wilson, J. Sparano, L. Ratner, 2013, Blood.

Model-Based Methodology for Analyzing Incomplete Quality-of-Life Data and Integrating Them into the Q-Twist Framework

N. Mounier, É. Lepage, H. Flechtner, 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

Factors predictive of early death in patients receiving high‐dose CHOP (ACVB regimen) for aggressive non‐Hodgkin's lymphoma: a GELA study

T. Molina, B. Coiffier, O. Casasnovas, 2002, British journal of haematology.

R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study

T. Molina, G. Salles, H. Tilly, 2009 .

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.

C. Katlama, D. Costagliola, N. Mounier, 2009, Critical reviews in oncology/hematology.

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

P. Gaulard, C. Gisselbrecht, N. Mounier, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

G. Salles, R. Bouabdallah, A. Stamatoullas, 2015 .

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study

S. Chevret, N. Mounier, D. Farge, 2002, British journal of haematology.

GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin’s B lymphomas via NF-κB-dependent induction of HIF-1α

G. Pagès, N. Mounier, V. Imbert, 2014, Leukemia.

The impact of pre‐ and post‐transplantation positron emission tomography using 18‐fluorodeoxyglucose on poor‐prognosis lymphoma patients undergoing autologous stem cell transplantation

C. Gisselbrecht, J. Larghero, N. Mounier, 2007, Cancer.

Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003-3).

B. Coiffier, O. Casasnovas, P. Feugier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA

B. Coiffier, N. Mounier, A. Delmer, 2014 .

ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.

J. Soulier, C. Gisselbrecht, N. Mounier, 2008, Clinical advances in hematology & oncology : H&O.

Personalized medicine in oncology: where have we come from and where are we going?

J. Blay, F. Penault-Llorca, F. André, 2013, Pharmacogenomics.

Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.

C. Gisselbrecht, N. Mounier, I. Madelaine, 2010, Clinical lymphoma, myeloma & leukemia.

Monosomal karyotype improves IPSS‐R stratification in MDS and AML patients treated with Azacitidine

N. Mounier, P. Auberger, T. Cluzeau, 2013, American journal of hematology.

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

P. Gaulard, R. Hustinx, O. Casasnovas, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study.

N. Schmitz, C. Gisselbrecht, N. Mounier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

D. Costagliola, N. Mounier, F. Raffi, 2015, Clinical Infectious Diseases.

Hodgkin Lymphoma in Patients with HIV Infection: A Review

N. Mounier, N. Martis, 2012, Current Hematologic Malignancy Reports.

Les patients et Internet

N. Mounier, T. Cluzeau, 2010 .

How to define intermediate stage in Hodgkin's lymphoma?

C. Gisselbrecht, C. Sebban, N. Mounier, 2005, European journal of haematology. Supplementum.

Pathologic and Clinical Features of 77 Hodgkin's Lymphoma Patients Treated in a Lymphoma Protocol (LNH87): A GELA Study

P. Gaulard, F. Berger, J. Diebold, 2001, The American journal of surgical pathology.

Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma

R. Lhommel, N. Mounier, L. Michaux, 2014, Leukemia and Lymphoma.

High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.

M. Pfreundschuh, C. Gisselbrecht, C. Crawley, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

P. Gaulard, B. Coiffier, H. Tilly, 2003, Blood.

Survival effect of darbepoetin alfa in patients with diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: The LNH03-6B study.

T. Molina, B. Coiffier, H. Tilly, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modern management of non‐Hodgkin lymphoma in HIV‐infected patients

C. Gisselbrecht, N. Mounier, M. Spina, 2007, British journal of haematology.

Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

C. Scott, J. Tanti, N. Mounier, 2013, Blood.

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.

N. Schmitz, G. Salles, J. Radford, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

A. Stamatoullas, O. Casasnovas, N. Mounier, 2015, Haematologica.

All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

A. Stamatoullas, F. Morschhauser, P. Feugier, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Myelodysplasia after autotransplantation.

C. Gisselbrecht, N. Mounier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas

T. Molina, C. Gisselbrecht, N. Mounier, 1998, Leukemia.

Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma.

C. Gisselbrecht, N. Mounier, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Patients and Methods: the Act Ii Trial Recruited 940 Patients Comparing 5fu-based Crt Using Cisplatin (cisp)

J. Ledermann, O. Casasnovas, N. Mounier, 2022 .

Quality of life following treatment for B-cell lymphoma

C. Gisselbrecht, N. Mounier, N. Martis, 2011, Expert review of pharmacoeconomics & outcomes research.

T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation

A. Cumano, N. Mounier, A. Janin, 2005 .

Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

A. Cumano, A. Régnault, N. Mounier, 2005, Experimental hematology.

CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications.

N. Mounier, J. Estaquier, A. Janin, 2002, Blood.

Significant Prognostic Impact of [18F]Fluorodeoxyglucose-PET Scan Performed During and At the End of Treatment with R-CHOP in High-Tumor Mass Follicular Lymphoma Patients: A GELA-GOELAMS Study

G. Salles, H. Tilly, N. Mounier, 2011 .

lymphoma patients: results of the GELA-GOELAMS FL2000 study Rituximab combined with chemotherapy and interferon in follicular

J. Rossi, G. Salles, R. Bouabdallah, 2013 .

ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial.

B. Coiffier, N. Mounier, P. Lugtenburg, 2012 .

Second-line therapy for lymphoid neoplasms

C. Gisselbrecht, N. Mounier, 2010 .

Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis

N. Mounier, M. Ebbo, N. Martis, 2019, European Radiology.

A Clinical Decision Support System for Prevention of Venous Thromboembolism

Philippe Ravaud, Pierre Durieux, Nicolas Mounier, 2013 .

study from the GELA patients with advanced follicular lymphoma: the GELF-94 randomized high-dose therapy with autologous stem cell transplantation in untreated Standard chemotherapy with interferon compared to CHOP followed by

G. Salles, B. Coiffier, R. Bouabdallah, 2013 .

Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab‐naive, recurrent/refractory follicular non‐Hodgkin lymphoma with high tumor burden

M. Copin, P. Feugier, H. Tilly, 2010, Cancer.

Estimating late adverse events using competing risks after autologous stem‐cell transplantation in aggressive non‐Hodgkin lymphoma patients

C. Gisselbrecht, J. Larghero, N. Mounier, 2005, Cancer.

Improving Second-Line Therapy in Aggressive Non-Hodgkin's Lymphoma.

C. Gisselbrecht, N. Mounier, 2004, Seminars in oncology.

T-Cell/Histiocyt e-Rich L arge B -Cell L ymphomas a nd C lassical Diffuse L arge B -Cell L ymphomas H ave S imilar O utcome A fter Chemotherapy: A M atched-Control A nalysis

T. Molina, P. Gaulard, R. Bouabdallah, 2003 .

High-dose therapy for indolent lymphoma.

C. Gisselbrecht, N. Mounier, G. Socié, 2002, Critical reviews in oncology/hematology.

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

F. Jardin, P. Gaulard, H. Tilly, 2018, Cancer medicine.

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor‐risk patients with diffuse large B‐cell lymphoma: results from a large cohort of patients

G. Salles, H. Tilly, N. Mounier, 2013, Transfusion.

Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.

P. Gaulard, B. Coiffier, R. Bouabdallah, 2012, Clinical lymphoma, myeloma & leukemia.

Lymphomes associés à l'infection par le virus de l'immunodéficience humaine

N. Mounier, F. Boué, 2011 .

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma.

P. Gaulard, B. Coiffier, C. Gisselbrecht, 2006, Haematologica.

FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

P. Gaulard, B. Coiffier, O. Casasnovas, 2004, Leukemia.

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.

B. Coiffier, O. Casasnovas, H. Tilly, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era

C. Gisselbrecht, N. Mounier, 2011, Current opinion in oncology.

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

J. Cayuela, C. Gisselbrecht, Weili Zhao, 2004, Blood.

Update of the FL2000 randomized trial combining rituximab to CHVP-Interferon in follicular lymphoma (FL) patients (pts).

G. Salles, O. Casasnovas, H. Tilly, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients

N. Mounier, C. Preudhomme, G. Robert, 2012, Oncotarget.

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: Final analysis of the GELA-GOELAMS FL2000 study with a 5-year follow-up

J. Rossi, G. Salles, R. Bouabdallah, 2007 .

Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.

B. Coiffier, P. Feugier, H. Tilly, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998, Cancer.

R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-cell lymphoma (DLBCL): Final analysis of the LNH03-6B GELA study.

T. Molina, G. Salles, H. Tilly, 2012 .

LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

N. Mounier, J. Tamburini, G. Robert, 2019, Leukemia.

Central nervous system involvement in AIDS‐related lymphomas

W. Wilson, J. Sparano, N. Mounier, 2016, British journal of haematology.

Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas

C. Gisselbrecht, N. Mounier, P. Brice, 2007, European Radiology.

New sequential treatment with chemotherapy and reduced‐intensity conditioning for allogeneic stem‐cell transplantation in very high‐risk acute myeloid leukemia

N. Mounier, L. Mannone, T. Cluzeau, 2011, American journal of hematology.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.

P. Gaulard, B. Coiffier, H. Tilly, 2001 .

Parenthood in survivors of Hodgkin lymphoma: An EORTC-GELA general population case-control study.

J. Raemaekers, A. Allgeier, N. Mounier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma

O. Casasnovas, N. Mounier, M. Erlanson, 2017, Bone Marrow Transplantation.

Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.

D. Costagliola, N. Mounier, F. Bonnet, 2019, AIDS.

Hodgkin lymphoma in the modern combined antiretroviral therapy era

D. Costagliola, N. Mounier, F. Bonnet, 2019 .

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS.

G. Salles, L. Xerri, P. Feugier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients

K. Baumstarck, D. Olive, N. Mounier, 2014, AIDS Research and Therapy.

Long-term results of the GELA study comparing R-CHOP and CHOP chemotherapy in older patients with diffuse large B-cell lymphoma show good survival in poor-risk patients

B. Coiffier, P. Feugier, H. Tilly, 2007 .

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.

N. Schmitz, C. Gisselbrecht, N. Mounier, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Monoclonal antibodies in the treatment of lymphoma].

C. Gisselbrecht, N. Mounier, 2002, La Revue du praticien.

Baseline total metabolic volume (TMTV) to predict the outcome of patients with advanced Hodgkin lymphoma (HL) enrolled in the AHL2011 LYSA trial.

G. Salles, R. Bouabdallah, A. Stamatoullas, 2016 .

Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications.

C. Katlama, E. Lanoy, D. Costagliola, 2012, European journal of cancer.

É. Oksenhendler, C. Katlama, D. Khayat, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

N. Mounier, P. Chérel, M. Janvier, 2005, Clinical lymphoma.

Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study

A. Rosenwald, N. Schmitz, P. Gaulard, 2010 .

Faculty Opinions recommendation of Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

N. Mounier, 2008 .

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

T. Molina, H. Tilly, B. Quesnel, 2005 .

Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations

V. Vanneaux, J. Larghero, N. Mounier, 2007, Bone Marrow Transplantation.

Quantification of urinary allantoin by capillary zone electrophoresis during recombinant urate oxydase (rasburicase) therapy.

C. Gisselbrecht, N. Mounier, P. Houzé, 2006, Clinical biochemistry.

des Lymphomes de l'Adulte (GELA) trials angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude Clinical, biologic, and pathologic features in 157 patients with

P. Gaulard, B. Coiffier, J. Diebold, 2013 .

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

P. Gaulard, B. Coiffier, J. Diebold, 2008, Blood.

Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.

P. Gaulard, F. Berger, B. Coiffier, 2006, Blood.

Managing large cell lymphoma.

C. Gisselbrecht, N. Mounier, 2006, Annals of Oncology.

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.

A. Stamatoullas, F. Morschhauser, P. Feugier, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multivariate analysis of the survival of patients with aggressive lymphoma

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998 .

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

N. Schmitz, J. Radford, C. Gisselbrecht, 2017, Bone Marrow Transplantation.

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

N. Schmitz, G. Salles, J. Radford, 2016, Bone Marrow Transplantation.

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.

W. Wilson, J. Sparano, L. Ratner, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia

A. Stamatoullas, P. Rohrlich, N. Mounier, 2019, International Journal of Molecular Sciences.

Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.

N. Mounier, M. Ticchioni, J. Haudebourg, 2010, Clinical advances in hematology & oncology : H&O.

GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.

B. Nadel, C. Copie-Bergman, T. Molina, 2019, Cell metabolism.

counts in follicular lymphoma Prognostic significance of bcl-xL gene expression and apoptotic cell

J. Cayuela, N. Mounier, A. Janin, 2013 .

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

P. Gaulard, F. Berger, B. Coiffier, 2003, Blood.

Long term hematologic recovery after autologous stem cell transplantation in lymphoma patients: impact of the number of prefreeze and post-thaw CD34+ cells.

C. Gisselbrecht, J. Larghero, N. Mounier, 2005, Bulletin du cancer.

Hodgkin lymphoma in HIV positive patients.

N. Mounier, J. Spano, M. Spina, 2010, Current HIV research.

B. Coiffier, C. Gisselbrecht, N. Mounier, 2006 .

l'Adulte (GELA) trials first-line polychemotherapy within the Groupe d'Etude des Lymphomes de with NK/T-cell lymphoma : results of a Western series of 48 patients treated Expression of the granzyme B inhibitor PI9 predicts outcome in nasal

F. Berger, C. Gisselbrecht, J. Bosq, 2013 .

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

P. Gaulard, F. Berger, C. Gisselbrecht, 2007, Blood.

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

O. Casasnovas, P. Gobbi, E. Iannitto, 2020, Cancer medicine.

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

G. Salles, B. Coiffier, R. Bouabdallah, 2006, Blood.

Diffuse Large B-Cell Lymphoma

N. Mounier, K. Dunleavy, S. Barta, 2016 .

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B‐cell lymphoma

G. Salles, C. Gisselbrecht, N. Mounier, 2009, Cancer.

Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression

É. Oksenhendler, C. Gisselbrecht, Weili Zhao, 2004, Laboratory Investigation.

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

B. Coiffier, F. Morschhauser, O. Casasnovas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

T. Molina, H. Tilly, B. Quesnel, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

G. Salles, F. Berger, A. Stamatoullas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, P. Biron, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

VEGF and VEGFR‐1 are coexpressed by epithelial and stromal cells of renal cell carcinoma

N. Mounier, P. Teillac, F. Calvo, 2008, Cancer.

Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study

T. Conroy, T. Petrella, B. Quesnel, 2002 .

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.

N. Mounier, A. Toubert, D. Farge, 2005, Arthritis and rheumatism.

Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

N. Mounier, P. Auberger, T. Cluzeau, 2013, Blood Cancer Journal.

Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

D. Costagliola, N. Mounier, F. Bonnet, 2021, AIDS.

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS (London).

In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study

D. Costagliola, N. Mounier, C. Chassagne‐Clément, 2020, British journal of haematology.

HCV or HBV coinfection and lymphoma risk in people living with HIV.

C. Katlama, D. Costagliola, N. Mounier, 2019, AIDS.

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era

D. Costagliola, N. Mounier, C. Récher, 2017, AIDS.

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

R. Bouabdallah, A. Stamatoullas, P. Feugier, 2019, The Lancet. Oncology.

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

P. Gaulard, G. Salles, A. Rahmouni, 2013, Haematologica.

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

C. Copie-Bergman, M. Baia, T. Molina, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

Catherine Thieblemont, Nicolas Mounier, Richard Delarue, 2013, The Lancet. Oncology.

The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.

A. Rosenwald, N. Schmitz, P. Gaulard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation

F. Jardin, P. Gaulard, H. Tilly, 2021, Leukemia & lymphoma.

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study.

J. Jais, P. Feugier, H. Tilly, 2017, Blood.

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA

G. Salles, O. Casasnovas, P. Feugier, 2011, Haematologica.

(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2011, Clinical lymphoma, myeloma & leukemia.

Chemotherapy and Interactions with Combination Antiretroviral Therapy

N. Mounier, M. Rudek, 2016 .

Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.

C. Gisselbrecht, N. Mounier, 2015, Expert review of hematology.

[Implications of ALK (anaplastic lymphoma kinase) in oncohematology].

N. Mounier, T. Cluzeau, S. Vignot, 2010, Bulletin du cancer.

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

G. Salles, L. Xerri, N. Brousse, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.

P. Gaulard, B. Quesnel, C. Gisselbrecht, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol

T. Molina, B. Coiffier, H. Tilly, 2010, Leukemia & lymphoma.

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study

A. Stamatoullas, H. Tilly, H. Kluin-Nelemans, 2019, Health and Quality of Life Outcomes.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

O. Casasnovas, N. Mounier, M. Erlanson, 2016 .

T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.

T. Molina, P. Gaulard, R. Bouabdallah, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study

B. Coiffier, H. Tilly, C. Gisselbrecht, 2007 .

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

R. Greil, P. Gaulard, B. Coiffier, 2019, British journal of haematology.

Autologous stem cell transplantation in elderly patients (≥60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry

M. Pfreundschuh, H. Tilly, D. Blaise, 2008, Haematologica.

Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).

C Sebban, G. Salles, R. Bouabdallah, 2000, Blood.

Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

N. Mounier, I. Fleury, P. Brice, 2016, Leukemia & lymphoma.

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.

P. Gaulard, G. Salles, M. Copin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[Peripherally inserted central catheters (PICC) in onco-hematology. PICC line in onco-hematology].

N. Mounier, L. Mannone, P. Chevallier, 2010, Bulletin du Cancer.

A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Études des Lymphomes de l'Adulte (GELA)

O. Casasnovas, N. Mounier, P. Lederlin, 2007, Leukemia & lymphoma.

Relapses, treatments and new drugs.

C. Gisselbrecht, N. Mounier, 2012, Best practice & research. Clinical haematology.

Lymphoplasmocytic malignant lymphoma presenting with spinal epidural involvement: Four reports of this uncommon lesion

N. Mounier, E. de Kerviler, P. Pautier, 1995, American journal of hematology.

Efficacy and toxicity of two schedules of R-CHOP plus bortezomib in front-line B lymphoma patients: A randomized phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

G. Salles, C. Gisselbrecht, N. Mounier, 2007 .

Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant

B. Coiffier, P. Feugier, H. Tilly, 2011, Leukemia & lymphoma.

High‐dose therapy and autologous stem‐cell transplantation can improve event‐free survival for indolent lymphoma

L. Quéro, C. Gisselbrecht, N. Mounier, 2007, Cancer.

Laparoendoscopic single-site ovariectomy: an indication of choice for ovarian cryopreservation

N. Mounier, J. Delotte, A. Bongain, 2013 .

Survival Impact of Rituximab Combined to ACVBP (R-ACVBP) in 209 Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Upfront High-Dose Consolidative Autotransplantation (HDC) : A GELA Phase II Study

B. Coiffier, O. Casasnovas, P. Feugier, 2008 .

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines

P. Rohrlich, N. Mounier, C. Preudhomme, 2014, Oncotarget.

Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study

B. Coiffier, H. Tilly, N. Mounier, 2015, Leukemia & lymphoma.

Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.

J. Blay, G. Salles, A. Stamatoullas, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pneumoblastoma: a rare lung tumour occurring as a long-term complication after allogeneic haematopoietic cell transplantation

N. Mounier, T. Cluzeau, J. Mouroux, 2010, Bone Marrow Transplantation.

Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

F. Jardin, N. Mounier, C. Haioun, 2021, Annals of Hematology.

Economic burden in non‐Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross‐sectional study

G. Salles, J. Jais, P. Feugier, 2021, Cancer.

Long‐term fatigue in survivors of non‐Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross‐sectional study

G. Salles, J. Jais, P. Feugier, 2019, Cancer.

Groupe d'Etude des Lymphomes de l'Adulte (GELA) patients with advanced-stage Hodgkin lymphoma: a study by the Long-term results and competing risk analysis of the H89 trial in

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2013 .

MYC diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

R. Houlgatte, P. Feugier, C. Gisselbrecht, 2016, Oncotarget.

or R-DHAP followed by BEAM plus autologous stem cell transplantation diffuse large B-cell lymphoma is not salvaged by classical R-ICE + MYC

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers.

P. Gaulard, R. Houlgatte, C. Gisselbrecht, 2017, Oncotarget.

Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma.

C. Gisselbrecht, N. Mounier, 2003, Seminars in oncology.

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

B. Coiffier, P. Feugier, H. Tilly, 2005 .

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment

G. Salles, F. Berger, B. Coiffier, 2014, Leukemia & lymphoma.

Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

F. Jardin, N. Mounier, C. Haioun, 2021, Annals of Hematology.

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2006, Blood.

Improving second-line therapy in aggressive non-Hodgkin's lymphoma.

C. Gisselbrecht, N. Mounier, 2004, Seminars in oncology.

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

O. Casasnovas, N. Mounier, M. André, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Secondary surgery with intraoperative chemohyperthermia in recurrent ovarian adenocarcinoma.

N. Mounier, E. Benizri, D. Benchimol, 2012 .

Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?

Nicolas Mounier, Stéphane Vignot, N. Mounier, 2016, Annals of medicine.

Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study.

T. Molina, G. Salles, R. Bouabdallah, 2013, Clinical advances in hematology & oncology : H&O.

Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma: a GELA experience.

C. Gisselbrecht, N. Mounier, P. Brice, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Current clinical trials for the treatment of adult advanced‐stage Hodgkin's disease: GELA experiences

N. Mounier, M. Diviné, C. Fermé, 2002 .

Rituximab compared to observation after high-dose consolidative first-line chemotherapy (HDC) with autologous stem cell transplantation in poor-risk diffuse large B-cell lymphoma: Updated results of the LNH98-B3 GELA study

B. Coiffier, H. Tilly, C. Gisselbrecht, 2007 .

Rituximab Combined to ACVBP (R-ACVBP) as a New Inductive Treatment Followed by High-Dose Consolidative Autotransplantation (HDC) for Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) in First-Line. Preliminary Results on 119 Patients of a GELA Phase II Study.

B. Coiffier, O. Casasnovas, H. Tilly, 2006 .

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

G. Salles, L. Xerri, N. Brousse, 2006 .

R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.

N. Schmitz, P. Gaulard, C. Gisselbrecht, 2007 .

MYC diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

J. Cayuela, C. Gisselbrecht, Weili Zhao, 2004, Blood.

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis

A. Rosenwald, M. Ziepert, T. Molina, 2023, Blood advances.

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: A multiinstitutional study of 246 patients.

E. Cotte, N. Mounier, F. Gilly, 2009, Journal of Clinical Oncology.

Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d’Etudes des Lymphomes de l’Adulte and GOELAMS

G. Salles, L. Xerri, P. Feugier, 2012 .

[Histone deacetylase inhibitors: highlight on epigenetic regulation].

N. Mounier, T. Cluzeau, C. Thibault, 2010, Bulletin du cancer.

MYC diffuse large B-cell lymphoma is not salvaged by classical RICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

Follicular lymphoma international prognostic index.

A. López-Guillermo, H. Tilly, P. Zinzani, 2004, Blood.

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

E. Cesarman, P. Moore, L. Ratner, 2023, The Lancet. Haematology.

Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.

D. Costagliola, N. Mounier, S. Prévôt, 2020, European journal of cancer.

Tumour-and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial †

O. Casasnovas, N. Mounier, A. Delmer, 2014 .

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.

J. Rossi, G. Salles, R. Bouabdallah, 2008, Blood.

G. Salles, L. Xerri, P. Feugier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical , biologic , and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d ’ Etude des Lymphomes de l ’ Adulte ( GELA ) trials

P. Gaulard, B. Coiffier, R. Bouabdallah, 2008 .

Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab‐naive, recurrent/refractory follicular non‐Hodgkin lymphoma with high tumor burden

M. Copin, P. Feugier, H. Tilly, 2010, Cancer.

Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2006 .

Relapses, treatments and new drugs.

C. Gisselbrecht, N. Mounier, 2012, Best practice & research. Clinical haematology.

Angioimmunoblastic T-Cell Lymphoma: A Clinicopathologic Study of 158 Patients Treated in GELA (Groupe d’ Etude des Lymphomes de l’ Adulte) Trials.

T. Molina, P. Gaulard, J. Diebold, 2006 .